Considerations for safety assessment of intractable proteins expressed in genetically modified crops

Current requirements for safety assessment by regulatory agencies necessitate the production of multi-gram quantities of functionally active proteins newly expressed in genetically modified (GM) crops. This presents challenges for so-called intractable proteins (those that are difficult to isolate in an active form). Significant experience and knowledge have been gained by both GM crop developers and global regulatory agencies regarding the safety assessment of the newly expressed proteins (NEPs). By leveraging this knowledge and scientific data that have accumulated over the last several decades, the safety assessments of NEPs can be refined and improved. In this technical review, we examine the options for characterizing intractable NEPs and producing protein test substances from different sources to support the safety assessments of novel GM crops.

Authors

Institutions

Publication Details

Journal
Journal of Regulatory Science
Published
2024-10-07
DOI
https://doi.org/10.21423/jrs.regsci.121291
Citations
1
Primary Topic
Genetically Modified Organisms Research
Type
article
Field-Weighted Citation Impact
0.60
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Considerations for safety assessment of intractable proteins expressed in genetically modified crops

Matthew L. Cheever, Matthew G. Pence, Yanfei Wang, Hélène Vigeolas et al.
1 citations
Journal of Regulatory Science
Genetically Modified Organisms Research
0.60
article

Considerations for safety assessment of intractable proteins expressed in genetically modified crops

Matthew L. Cheever, Matthew G. Pence, Yanfei Wang, Hélène Vigeolas, Barry W. Schafer, Rod A. Herman, Christopher Ament, Rong Wang, Jian Wu, Tao Geng, John Zhang, Brandy Verhalen, Pei-Ying Wu
article en
1 citations

Abstract

Current requirements for safety assessment by regulatory agencies necessitate the production of multi-gram quantities of functionally active proteins newly expressed in genetically modified (GM) crops. This presents challenges for so-called intractable proteins (those that are difficult to isolate in an active form). Significant experience and knowledge have been gained by both GM crop developers and global regulatory agencies regarding the safety assessment of the newly expressed proteins (NEPs). By leveraging this knowledge and scientific data that have accumulated over the last several decades, the safety assessments of NEPs can be refined and improved. In this technical review, we examine the options for characterizing intractable NEPs and producing protein test substances from different sources to support the safety assessments of novel GM crops.

Journal of Regulatory ScienceVol. 12(1)
Simplot (United States) (US), BASF (United States) (US), Scientific Solutions (United States) (US), Corteva (United States) (US), Eurofins (France) (FR), Syngenta (China) (CN), V.F. Corporation (United States), Bayer (Germany) (DE)
Openalex Percentile: Top 21%
Genetically Modified Organisms Research
0.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.